Since taking office in January, President Joe Biden has sought to undo several policies that were established during Donald Trump’s administration. This week, the Biden administration announced another reversal of a Trump-era policy that limited healthcare protections for transgender people.
Health and Human Services Secretary Xavier Becerra announced that the Biden administration is undoing a Trump-era policy against transgender people in healthcare. The rollback was finalized by the Trump administration in June 2020. The protection for transgender people was also regulated by Obamacare, which Trump and the Republicans sought to repeal.
“The Supreme Court has made clear that people have a right not to be discriminated against on the basis of sex and receive equal treatment under the law, no matter their gender identity or sexual orientation. That’s why today HHS announced it will act on related reports of discrimination,” Becerra said in a statement.
“Fear of discrimination can lead individuals to forego care, which can have serious negative health consequences. It is the position of the Department of Health and Human Services that everyone - including LGBTQ people - should be able to access health care, free from discrimination or interference, period,” added Becerra.
Becerra also noted the provision in the Affordable Care Act regarding the protections in an interview with CNN Monday. During Trump’s presidency, HHS announced that it would only recognize discrimination according to the “plain meaning of the world ‘sex’ as male or female and as determined by biology.” The Supreme Court would later rule that the existing federal law prohibits job discrimination based on gender identity or sexual orientation.
Previously, Reuters reported that Biden threw his support towards a proposal made by India and South Africa on temporarily waiving IP patents on COVID-19 vaccines to make them more accessible, especially towards developing countries. Biden confirmed his support for the waiver in his comments to the press.
US Trade Representative Katherine Tai also issued a statement furthering the US’ support for temporarily waiving the IP patents, especially at a time of great need. Many Democratic lawmakers have pushed for a temporary waiver, as did many other countries, despite criticism from the pharmaceutical companies.


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Epstein Files Released by DOJ Spotlight Bill Clinton, Raise Questions Over Trump Mentions
Putin Envoy Heads to Miami for High-Stakes Talks as U.S. Pushes Ukraine Peace Deal
Brazil Court Allows Bolsonaro Hospital Trip Amid Prison Sentence
Trump Defends Economic Record in North Carolina as Midterm Election Pressure Mounts
Trump Signals Progress in Ukraine Peace Talks Ahead of U.S.–Russia Meeting
EU Delays Mercosur Free Trade Agreement Signing Amid Ukraine War Funding Talks
Canada Signals Delay in US Tariff Deal as Talks Shift to USMCA Review
Trump Nominates Lt. Gen. Frank Donovan to Lead U.S. Southern Command Amid Rising Tensions in Latin America
U.S. Intelligence Warns Putin Still Seeks Full Control of Ukraine Despite Peace Talks
Trump Expands U.S. Travel Ban to Antigua and Barbuda, Dominica, Sparking Economic Fears in the Caribbean
U.S. and China Push for Ceasefire as Thailand–Cambodia Border Clashes Escalate
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Fernando Haddad Confirms He Will Not Run for Office in 2025, Signals Possible Exit as Brazil’s Finance Minister
EU Approves €90 Billion Ukraine Aid as Frozen Russian Asset Plan Stalls
U.S. Initiates $11.1 Billion Arms Sale to Taiwan Amid Rising China Tensions 



